Cargando…

Epigenetic Therapies and Biomarkers in Breast Cancer

SIMPLE SUMMARY: Epigenetic therapies are promising agents for overcoming clinical resistance to conventional treatments in breast cancer. In the assessed trials, the use of epigenetic therapies for the management of breast cancer has not translated from the pre-clinical to clinical setting. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Lauren Julia, Achinger-Kawecka, Joanna, Portman, Neil, Clark, Susan, Stirzaker, Clare, Lim, Elgene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833457/ https://www.ncbi.nlm.nih.gov/pubmed/35158742 http://dx.doi.org/10.3390/cancers14030474

Ejemplares similares

Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer
por: Freelander, Allegra, et al.
Publicado: (2021)

MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer
por: Portman, Neil, et al.
Publicado: (2021)

Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations
por: Taberlay, Phillippa C., et al.
Publicado: (2016)

Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer
por: Achinger-Kawecka, Joanna, et al.
Publicado: (2020)

Advances in Prognostic Methylation Biomarkers for Prostate Cancer
por: Lam, Dilys, et al.
Publicado: (2020)

Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains
por: Khoury, Amanda, et al.
Publicado: (2020)

Integrated epigenomic analysis stratifies chromatin remodellers into distinct functional groups
por: Giles, Katherine A., et al.
Publicado: (2019)

Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality
por: Pidsley, Ruth, et al.
Publicado: (2022)

The Assessment of Clinical Usage and Prognostic Value of YKL-40 Serum Levels in Patients With Rectal Cancer Without Distant Metastasis
por: Fuksiewicz, Malgorzata, et al.
Publicado: (2018)

Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis
por: Locke, Warwick J, et al.
Publicado: (2015)

Heart Failure Therapies for the Prevention of HER2-Monoclonal Antibody-Mediated Cardiotoxicity: A Systematic Review and Meta-Analysis of Randomized Trials
por: Brown, Lauren J., et al.
Publicado: (2021)

Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic
por: Kumar, Sanjeev, et al.
Publicado: (2021)

Antibody–Drug Conjugates: Ushering in a New Era of Cancer Therapy
por: Hurwitz, Joshua, et al.
Publicado: (2023)

Effects of Endocrine Therapy on Cognitive Function in Patients with Breast Cancer: A Comprehensive Review
por: Haggstrom, Lucy R., et al.
Publicado: (2022)

BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer
por: Giles, Katherine A., et al.
Publicado: (2021)

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
por: Alves, Carla L., et al.
Publicado: (2021)

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
por: Alves, Carla L., et al.
Publicado: (2021)

Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER‐positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor
por: Karimi, Leena, et al.
Publicado: (2023)

Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status
por: Downton, Teesha, et al.
Publicado: (2022)

MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer
por: Portman, Neil, et al.
Publicado: (2020)

The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy
por: Law, Andrew M K, et al.
Publicado: (2017)

Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Meyer, Braydon, et al.
Publicado: (2021)

Renewed interest in the progesterone receptor in breast cancer
por: Lim, Elgene, et al.
Publicado: (2016)

Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA
por: Szczepanek, Joanna, et al.
Publicado: (2023)

The Proliferative and Apoptotic Landscape of Basal-like Breast Cancer
por: Alexandrou, Sarah, et al.
Publicado: (2019)

Impact of Stilbenes as Epigenetic Modulators of Breast Cancer Risk and Associated Biomarkers
por: Ganguly, Sebanti, et al.
Publicado: (2021)

Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer
por: Sarvari, Pourya, et al.
Publicado: (2022)

The role of MDM2 and MDM4 in breast cancer development and prevention
por: Haupt, Sue, et al.
Publicado: (2017)

Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers
por: Rafikova, Guzel, et al.
Publicado: (2023)

miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
por: Mathe, Andrea, et al.
Publicado: (2015)

Epigenetic Therapy for Breast Cancer
por: Cai, Feng-Feng, et al.
Publicado: (2011)

Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer
por: Liu, Wenjie, et al.
Publicado: (2019)

Nutrition in Cancer Therapy in the Elderly—An Epigenetic Connection?
por: Blasiak, Janusz, et al.
Publicado: (2020)

DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients
por: Mathe, Andrea, et al.
Publicado: (2016)

The epigenetics of breast cancer – Opportunities for diagnostics, risk stratification and therapy
por: Schröder, Rieke, et al.
Publicado: (2021)

MethPanel: a parallel pipeline and interactive analysis tool for multiplex bisulphite PCR sequencing to assess DNA methylation biomarker panels for disease detection
por: Luu, Phuc-Loi, et al.
Publicado: (2020)

Epigenetics and Breast Cancers
por: Vo, An T., et al.
Publicado: (2012)

Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition
por: Aziz, Diar, et al.
Publicado: (2021)

Prognostic and Predictive Epigenetic Biomarkers in Oncology
por: Kamińska, Katarzyna, et al.
Publicado: (2018)

Epigenetics in Breast Cancer Therapy—New Strategies and Future Nanomedicine Perspectives
por: Buocikova, Verona, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6vmkn2k3dea89hf3tanp98nmh7